Biologically optimized nanosized molecules and particles: More than just size

Bioconjugate Chemistry

Volumn 22, Issue 6, 2011, Pages 993-1000

  Longmire, Michelle R ^a   Ogawa, Mikako ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL APPLICATIONS; PARTICLE SIZE; SYNTHESIS (CHEMICAL);

BIODISTRIBUTIONS; BIOLOGICAL CHARACTERISTIC; CHEMICAL AND BIOLOGICALS; CHEMICAL CHARACTERISTIC; CONTRAST AGENT; HYDRODYNAMIC SIZE; IMAGING AGENT; IN-VIVO; PARTICLE SHAPE; PARTICLES SIZES;

MOLECULES;

DENDRIMER; MACROGOL; NANOPARTICLE; POLYAMIDOAMINE;

BIOACCUMULATION; CHEMICAL MODIFICATION; DRUG CLEARANCE; DRUG DISTRIBUTION; HUMAN; HYDRODYNAMICS; HYDROPHILICITY; IMAGING; IN VIVO STUDY; LIGHT SCATTERING; MOLECULE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PROCESS OPTIMIZATION; REVIEW;

EID: 79959273056     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200111p     Document Type: Review

References (75)

1. Alexis, F., Pridgen, E., Molnar, L. K., and Farokhzad, O. C. (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5, 505-15
2. Bartneck, M., Keul, H. A., Zwadlo-Klarwasser, G., and Groll, J. (2010) Phagocytosis independent extracellular nanoparticle clearance by human immune cells Nano Lett. 10, 59-63
3. Briley-Saebo, K. C., Johansson, L. O., Hustvedt, S. O., Haldorsen, A. G., Bjørnerud, A., Fayad, Z. A., and Ahlstrom, H. K. (2006) Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism Invest. Radiol. 41, 560-71 (Pubitemid 44284178)
4. Bulte, J. W. and Kraitchman, D. L. (2004) Iron oxide MR contrast agents for molecular and cellular imaging NMR Biomed. 17, 484-99 (Pubitemid 39549426)
5. Choi, H. S., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., and Frangioni, J. V. (2007) Renal clearance of quantum dots Nat. Biotechnol. 25, 1165-70 (Pubitemid 47538116)
6. Choi, H. S., Liu, W., Liu, F., Nasr, K., Misra, P., Bawendi, M. G., and Frangioni, J. V. (2010) Design considerations for tumour-targeted nanoparticles Nat. Nanotechnol. 5, 42-7
7. Gonçalves, C., Torrado, E., Martins, T., Pereira, P., Pedrosa, J., and Gama, M. (2010) Dextrin nanoparticles: studies on the interaction with murine macrophages and blood clearance Colloids Surf., B: Biointerfaces 75, 483-9
8. He, X., Nie, H., Wang, K., Tan, W., Wu, X., and Zhang, P. (2008) In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles Anal. Chem. 80, 9597-603
9. Jain, T. K., Reddy, M. K., Morales, M. A., Leslie-Pelecky, D. L., and Labhasetwar, V. (2008) Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats Mol. Pharm. 5, 316-27 (Pubitemid 351579134)
10. Kobayashi, H., Sato, N., Kawamoto, S., Saga, T., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine Magn. Reson. Med. 46, 457-64 (Pubitemid 32831319)
11. Longmire, M., Choyke, P. L., and Kobayashi, H. (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine (Lond.) 3, 703-17
12. Schipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., Chen, X., Banin, U., Wu, A. M., Sinclair, R., Weiss, S., and Gambhir, S. S. (2009) Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice Small 5, 126-34
13. Sigovan, M., Boussel, L., Sulaiman, A., Sappey-Marinier, D., Alsaid, H., Desbleds-Mansard, C., Ibarrola, D., Gamondès, D., Corot, C., Lancelot, E., Raynaud, J. S., Vives, V., Laclédère, C., Violas, X., Douek, P. C., and Canet-Soulas, E. (2009) Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model Radiology 252, 401-9
14. Kobayashi, H., Kawamoto, S., Jo, S. K., Bryant, H. L., Brechbiel, M. W., and Star, R. A. (2003) Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores Bioconjugate Chem. 14, 388-94 (Pubitemid 36348662)
15. Kobayashi, H. and Brechbiel, M. W. (2004) Dendrimer-based nanosized MRI contrast agents Curr. Pharm. Biotechnol. 5, 539-49 (Pubitemid 39654851)
16. Kobayashi, H., Jo, S. K., Kawamoto, S., Yasuda, H., Hu, X., Knopp, M. V., Brechbiel, M. W., Choyke, P. L., and Star, R. A. (2004) Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure J. Magn. Reson. Imaging 20, 512-8 (Pubitemid 39121952)
17. Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents Magn. Reson. Med. 46, 781-8 (Pubitemid 32906148)
18. Tomalia, D. A. (2009) In quest of a systematic framework for unifying and defining nanoscience J. Nanopart. Res. 11, 1251-1310
19. Kobayashi, H. and Brechbiel, M. W. (2005) Nano-sized MRI contrast agents with dendrimer cores Adv. Drug Delivery Rev. 57, 2271-86 (Pubitemid 41759396)
20. Sato, N., Kobayashi, H., Hiraga, A., Saga, T., Togashi, K., Konishi, J., and Brechbiel, M. W. (2001) Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores Magn. Reson. Med. 46, 1169-73 (Pubitemid 33104305)
21. Canelas, D. A., Herlihy, K. P., and DeSimone, J. M. (2009) Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 391-404
22. Sadekar, S., Ray, A., Janàt-Amsbury, M., Peterson, C. M., and Ghandehari, H. (2011) Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice Biomacromolecules 12, 88-96
23. Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., and Discher, D. E. (2007) Shape effects of filaments versus spherical particles in flow and drug delivery Nat. Nanotechnol. 2, 249-55 (Pubitemid 46739812)
24. Arnida, Janát-Amsbury, M. M., Ray, A., Peterson, C. M., and Ghandehari, H. (2010) Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur. J. Pharm. Biopharm.
25. Kojima, C., Regino, C., Umeda, Y., Kobayashi, H., and Kono, K. (2010) Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers Int. J. Pharm. 383, 293-6
26. Owens, D. E. and Peppas, N. A. (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307, 93-102 (Pubitemid 41773257)
27. Sheng, Y., Yuan, Y., Liu, C., Tao, X., Shan, X., and Xu, F. (2009) In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content J. Mater. Sci. Mater. Med. 20, 1881-91
28. Gaumet, M., Vargas, A., Gurny, R., and Delie, F. (2008) Nanoparticles for drug delivery: the need for precision in reporting particle size parameters Eur. J. Pharm. Biopharm. 69, 1-9 (Pubitemid 351467152)
29. Ogawa, M., Regino, C. A., Marcelino, B., Williams, M., Kosaka, N., Bryant, L. H., Jr., Choyke, P. L., and Kobayashi, H. (2010) New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules Bioconjugate Chem. 21, 955-60
30. Kobayashi, H., Sato, N., Kawamoto, S., Saga, T., Hiraga, A., Haque, T. L., Ishimori, T., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer Bioconjugate Chem. 12, 100-7 (Pubitemid 32111459)
31. Kobayashi, H., Saga, T., Kawamoto, S., Sato, N., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64) Cancer Res. 61, 4966-70 (Pubitemid 32681519)
32. Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Ishimori, T., Akita, Y., Mamede, M. H., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core Magn. Reson. Med. 46, 795-802 (Pubitemid 32906150)
33. Dear, J. W., Kobayashi, H., Jo, S. K., Holly, M. K., Hu, X., Yuen, P. S., Brechbiel, M. W., and Star, R. A. (2005) Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice Kidney Int. 67, 2159-67 (Pubitemid 41623377)
34. Kobayashi, H., Kawamoto, S., Jo, S., Sato, N., Saga, T., Hiraga, A., Konishi, J., Hu, S., Togashi, K., Brechbiel, M. W., and Star, R. A. (2002) Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based MR contrast agent Kidney Int. 61, 1980-5 (Pubitemid 34539315)
35. Kobayashi, H., Sato, N., Hiraga, A., Saga, T., Nakamoto, Y., Ueda, H., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties Magn. Reson. Med. 45, 454-60 (Pubitemid 32173273)
36. Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents J. Magn. Reson. Imaging 14, 705-13 (Pubitemid 33101529)
37. Kobayashi, H., Sato, N., Kawamoto, S., Saga, T., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., and Brechbiel, M. W. (2001) 3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent Magn. Reson. Med. 46, 579-85 (Pubitemid 32831335)
38. Xu, R., Wang, Y., Wang, X., Jeong, E. K., Parker, D. L., and Lu, Z. R. (2007) In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent Exp. Biol. Med. (Maywood) 232, 1081-9 (Pubitemid 47358191)
39. Kobayashi, H. and Brechbiel, M. W. (2003) Dendrimer-based macromolecular MRI contrast agents: characteristics and application Mol. Imaging 2, 1-10
40. Kobayashi, H., Ogawa, M., Kosaka, N., Choyke, P. L., and Urano, Y. (2009) Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents Nanomedicine (Lond.) 4, 411-9
41. Kobayashi, H., Kawamoto, S., Choyke, P. L., Sato, N., Knopp, M. V., Star, R. A., Waldmann, T. A., Tagaya, Y., and Brechbiel, M. W. (2003) Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography Magn. Reson. Med. 50, 758-66 (Pubitemid 37187841)
42. Koyama, Y., Talanov, V. S., Bernardo, M., Hama, Y., Regino, C. A., Brechbiel, M. W., Choyke, P. L., and Kobayashi, H. (2007) A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice J. Magn. Reson. Imaging 25, 866-71 (Pubitemid 46516742)
43. Sena, L. M., Fishman, S. J., Jenkins, K. J., Xu, H., Brechbiel, M. W., Regino, C. A., Kosaka, N., Bernardo, M., Choyke, P. L., and Kobayashi, H. (2010) Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models Nanomedicine (Lond.) 5, 1183-91
44. Hama, Y., Koyama, Y., Urano, Y., Choyke, P. L., and Kobayashi, H. (2007) Two-color lymphatic mapping using Ig-conjugated near infrared optical probes J. Invest. Dermatol. 127, 2351-6 (Pubitemid 47619761)
45. Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., Cohn, L. H., Bawendi, M. G., and Frangioni, J. V. (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping Nat. Biotechnol. 22, 93-7 (Pubitemid 38057962)
46. Kobayashi, H., Kawamoto, S., Bernardo, M., Brechbiel, M. W., Knopp, M. V., and Choyke, P. L. (2006) Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging J. Controlled Release 111, 343-51
47. Kobayashi, H., Kawamoto, S., Sakai, Y., Choyke, P. L., Star, R. A., Brechbiel, M. W., Sato, N., Tagaya, Y., Morris, J. C., and Waldmann, T. A. (2004) Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent J. Natl. Cancer Inst. 96, 703-8 (Pubitemid 38660233)
48. Kobayashi, H., Kawamoto, S., Star, R. A., Waldmann, T. A., Tagaya, Y., and Brechbiel, M. W. (2003) Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent Cancer Res. 63, 271-6 (Pubitemid 36152478)
49. Kobayashi, H., Kawamoto, S., Brechbiel, M. W., Bernardo, M., Sato, N., Waldmann, T. A., Tagaya, Y., and Choyke, P. L. (2005) Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle Neoplasia 7, 984-91
50. Kobayashi, H., Hama, Y., Koyama, Y., Barrett, T., Regino, C. A., Urano, Y., and Choyke, P. L. (2007) Simultaneous multicolor imaging of five different lymphatic basins using quantum dots Nano Lett. 7, 1711-6 (Pubitemid 47140450)
51. Kobayashi, H., Koyama, Y., Barrett, T., Hama, Y., Regino, C. A., Shin, I. S., Jang, B. S., Le, N., Paik, C. H., Choyke, P. L., and Urano, Y. (2007) Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging ACS Nano 1, 258-64
52. Mounzer, R., Shkarin, P., Papademetris, X., Constable, T., Ruddle, N. H., and Fahmy, T. M. (2007) Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent Lymphat. Res. Biol. 5, 151-8 (Pubitemid 350172940)
53. Kono, K., Kojima, C., Hayashi, N., Nishisaka, E., Kiura, K., Watarai, S., and Harada, A. (2008) Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin Biomaterials 29, 1664-75
54. Kojima, C., Kono, K., Maruyama, K., and Takagishi, T. (2000) Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs Bioconjugate Chem. 11, 910-7
55. Sato, N., Kobayashi, H., Saga, T., Nakamoto, Y., Ishimori, T., Togashi, K., Fujibayashi, Y., Konishi, J., and Brechbiel, M. W. (2001) Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice Clin. Cancer Res. 7, 3606-12 (Pubitemid 33070001)
56. Choyke, P. L. and Kobayashi, H. (2006) Functional magnetic resonance imaging of the kidney using macromolecular contrast agents Abdom. Imaging 31, 224-31
57. Kobayashi, H., Reijnders, K., English, S., Yordanov, A. T., Milenic, D. E., Sowers, A. L., Citrin, D., Krishna, M. C., Waldmann, T. A., Mitchell, J. B., and Brechbiel, M. W. (2004) Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation Clin. Cancer Res. 10, 7712-20 (Pubitemid 39557536)
58. Kaneshiro, T. L., Jeong, E. K., Morrell, G., Parker, D. L., and Lu, Z. R. (2008) Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography Biomacromolecules 9, 2742-8
59. Xu, R., Kaneshiro, T. L., Jeong, E. K., Parker, D. L., and Lu, Z. R. (2010) Synthesis and evaluation of nanoglobule-cystamine-(Gd-DO3A), a biodegradable nanosized magnetic resonance contrast agent for dynamic contrast-enhanced magnetic resonance urography Int. J. Nanomed. 5, 707-13
60. Yang, W., Barth, R. F., Adams, D. M., and Soloway, A. H. (1997) Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors Cancer Res. 57, 4333-9 (Pubitemid 27413443)
61. Kono, K., Liu, M., and Frechet, J. M. (1999) Design of dendritic macromolecules containing folate or methotrexate residues Bioconjugate Chem. 10, 1115-21
62. Sideratou, Z., Kontoyianni, C., Drossopoulou, G. I., and Paleos, C. M. (2010) Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system Bioorg. Med. Chem. Lett. 20, 6513-7
63. Wiener, E. C., Konda, S., Shadron, A., Brechbiel, M., and Gansow, O. (1997) Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor Invest. Radiol. 32, 748-54 (Pubitemid 28053506)
64. Zhang, Y., Sun, Y., Xu, X., Zhang, X., Zhu, H., Huang, L., Qi, Y., and Shen, Y. M. (2010) Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates J. Med. Chem. 53, 3262-72
65. Cao, W., Zhou, J., Wang, Y., and Zhu, L. (2010) Synthesis and in vitro cancer cell targeting of folate-functionalized biodegradable amphiphilic dendrimer-like star polymers Biomacromolecules 11, 3680-7
66. Glickson, J. D., Lund-Katz, S., Zhou, R., Choi, H., Chen, I. W., Li, H., Corbin, I., Popov, A. V., Cao, W., Song, L., Qi, C., Marotta, D., Nelson, D. S., Chen, J., Chance, B., and Zheng, G. (2008) Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents Mol. Imaging 7, 101-10
67. Konda, S. D., Aref, M., Wang, S., Brechbiel, M., and Wiener, E. C. (2001) Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts MAGMA 12, 104-13 (Pubitemid 32510128)
68. Wijagkanalan, W., Kawakami, S., and Hashida, M. (2010) Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations. Pharm. Res.
69. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Buhler, K. R., and Vessella, R. L. (1998) Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers Bioconjugate Chem. 9, 813-25 (Pubitemid 28542250)
70. Mamede, M., Saga, T., Ishimori, T., Higashi, T., Sato, N., Kobayashi, H., Brechbiel, M. W., and Konishi, J. (2004) Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex J. Controlled Release 95, 133-41 (Pubitemid 38167687)
71. Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Ishimori, T., Konishi, J., Ono, K., Togashi, K., and Brechbiel, M. W. (2001) Avidin-dendrimer-(1B4M-Gd) (254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI Bioconjugate Chem. 12, 587-93 (Pubitemid 32696233)
72. Xu, H., Regino, C. A., Koyama, Y., Hama, Y., Gunn, A. J., Bernardo, M., Kobayashi, H., Choyke, P. L., and Brechbiel, M. W. (2007) Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging Bioconjugate Chem. 18, 1474-82 (Pubitemid 47464054)
73. Baker, J. R., Jr. (2009) Dendrimer-based nanoparticles for cancer therapy Hematol. Am. Soc. Hematol. Educ. Program 708-19
74. Majoros, I. J., Williams, C. R., and Baker, J. R., Jr. (2008) Current dendrimer applications in cancer diagnosis and therapy Curr. Top. Med. Chem. 8, 1165-79
75. Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mule, J., and Baker, J. R., Jr. (2002) Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor Pharm. Res. 19, 1310-6